Veranex, a provider of tech-enabled services, completed the acquisition of Medidee, a provider of clinical compliance services. Financial terms were not disclosed. “Our acquisition of Medidee significantly expands our European footprint while also materially expanding the scale and scope of the clinical studies we can manage. The combined organization offers offices and expertise across Europe, the US, and Asia, augmenting our ability to help MedTech innovators achieve FDA and CE Mark approvals and uninterrupted market access for new as well as proven medical technologies that advance patient care," David Dockhorn, Veranex CEO.